Prolonged or too frequent administration of the drug in young children can lead to central nervous system inhibition, hypothermia, coma, prolonged pupil dilation. Naphazoline can cause a sudden decrease in blood pressure and tachycardia.
There are no data concerning acute overdose of drops injected topically into the conjunctival sac.
Hypersensitivity.
Drowsiness, dry mouth, dizziness, nausea, headache, weakness, numbness of the mucous membranes, decreased reaction rate.
Drowsiness, dizziness, decreased reaction time, headache, weakness, dry mouth, numbness of the mucous membranes, nausea.
Increased excitability (especially in children).
Allergic diseases, allergic dermatoses, stomach and duodenal ulcer, insomnia, vomiting of pregnant women, Meniere's syndrome, seasickness, radiation sickness, Parkinsonism.
Allergic diseases, allergic dermatoses, stomach and duodenal ulcer, insomnia, vomiting of pregnant women, Meniere's syndrome, seasickness, radiation sickness, Parkinsonism.
Allergic reactions of the upper respiratory tract (runny nose, watery eyes, sore throat or nose), colds.
Alka-Seltzer (diphenhydramine)
Diphenhydramine
No information provided.
In/m — 1-5 ml of 1% solution.
Inside-0.025–0.05 g (for children-0.01-0.03 g) 1-3 times a day. The course is 10-15 days.
Externally. Adults and children over 2 years of age Alka-Seltzer (diphenhydramine)® apply to the affected areas of the skin (a strip of gel 3-5 cm long on the area of the lesion the size of the palm) 3-4 times a day and distribute with light massaging movements.
In/m — 1-5 ml of 1% solution. Inside, adults-25-50 mg 1-3 times a day.
Children — 10-30 mg 1-3 times a day. The course is 10-15 days.
Inside, adults — 2 tablets. every 6 hours, but no more than 12 tablets. per day.
Children from 6 to 12 years — 1 table. (no more than 6) per day. Children under 6 years of age need to consult a doctor.
